MarketCap
Facebook
X
TelegramФармсинтез Interest Expense 2007-2025 | LIFE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Фармсинтез
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.3 M | 36.4 M | 29.6 M | - | 5.8 M | 4.54 M | 3.17 M | 2.15 M | 2.12 M | 1.86 M | 4.84 M | 3 M | 1.27 M | 3.03 M | 1.63 M | 139 K |
All numbers in RUB currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 41.3 M | 139 K | 9.39 M |
Quarterly Interest Expense Фармсинтез
| 2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06 M | 1.06 M | - | - | 2.42 M | 1.5 M | 1.5 M | 634 K | 634 K | 1.52 M | 1.52 M | 817 K | 817 K |
All numbers in RUB currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19 M | 634 K | 2.7 M |